01 · The proposed name and what it hides
The label may describe the visible problem while hiding the driver underneath.
“Alcoholic”, “misuse”, “relapse”, “non-compliance”, “dual diagnosis” and “comorbidity” can all be true descriptions — and still flatten the sequence.
For some people, alcohol or other self-medication first does the neurological work untreated ADHD leaves undone. Only later does that compensating pattern cross into dependence, crisis and repeated presentation.
NIA is being proposed because ordinary comorbidity language can be too blunt. It can place two diagnoses side by side without asking whether one condition has been driving the other pathway for years.
Why the name matters
A name does not prove a category. But it can make the right question visible. The purpose of NIA is not to replace existing diagnoses; it is to ask whether a visible addiction pathway is sometimes the downstream expression of an untreated neurological driver.
02 · Re-reading the diagnoses
The same records can look different when the ADHD mechanism is considered.
Alcohol dependence, relapse, repeated crisis presentation, non-engagement, treatment failure and emotional chaos may not be separate character failures or disconnected clinical facts.
Read through an ADHD lens, the same pattern may show impaired routine, working memory breakdown, impulsivity, emotional dysregulation, recovery work not landing, and self-medication becoming dependence over time.
This does not make addiction less real. It asks whether the clinical sequence has been read in the wrong order.
Self-medication first, dependence later
The proposed NIA framing separates the early functional role of alcohol or substances from the later dependent pathway. The point is not excuse-making. The point is mechanism: what was the substance doing before it became the visible crisis?
Non-engagement may be a symptom of the driver
Missed appointments, failed routines, emotional volatility and apparent “non-compliance” may require a different reading when executive function, attention, working memory and impulse control are impaired.
Medication timing
The medication does not do the recovery work.
It creates the conditions where it can finally land.
For Dean, the recovery work, meetings, therapy, learning and support were already there. What changed was that the ADHD underneath was finally being addressed. The same work could finally stick.
03 · A Neurologically Informed Addiction framing
Looking through the ADHD lens, this is not ordinary comorbidity.
The ADHD Lens is not watching the person. It is seeing the pattern correctly.
NIA is proposed founder-originated terminology offered for clinical consideration, research and service design. It is a working clinical lens, not a diagnosis and not a formal consensus rename.
PMOS is useful only as an analogy: medicine sometimes renames or reframes a condition when the old name keeps attention on the wrong feature. NIA has not gone through that process; it simply makes the right question visible for review.
ADHD is heavily over-represented in addiction cohorts.
START France 2025 reported 61.3% improvement in addictive-disorder outcomes at six months after ADHD diagnosis and treatment.
A clinical receipt can help make the suspected ADHD–addiction mechanism explicit without turning OTOS into a clinical decision-maker.
04 · The Dual Screen
If addiction is visible, ADHD should be considered. If ADHD is known or suspected, addiction risk should be considered.
This is screening logic, not a diagnostic instrument. It is a recognition frame for clinical consideration, not an OTOS assessment and not a replacement for clinical judgement.
Addiction visible
Alcohol dependence, relapse, repeated crisis presentation, detox, A&E, treatment failure or apparent non-engagement.
- What is on fire?
- What has repeatedly failed to hold?
- Could self-medication have been doing neurological work?
ADHD driver considered
Attention, impulsivity, emotional regulation, working memory, routine failure and treatment learning that does not stick.
- Is ADHD known or suspected?
- Is addiction risk being considered?
- What sequencing would make the pathway hold?
- CGL-led / adjacent precedent
- Prison / justice settings
- Dual-diagnosis examples
- Mainstream ADHD-team-led public gap
- CPFT possible route
05 · Integrated practice
Not joining up the services. Holding the person across them.
If the NIA lens is worth testing, the practical question is not how OTOS takes over care. It is how an external, consent-led continuity layer can help the person stay held while services remain separate.
Holding the person across them.
What OTOS is
What OTOS is not
OTOS is
- non-clinical infrastructure
- external continuity layer
- consent-led support
- process visibility
- human-reviewed learning
OTOS is not
- diagnosis
- prescribing
- treatment
- clinical decision-making
- NHS record-writing
- merged EPR
- service-to-service data sharing
The first ask is routing: who is the correct buyer, innovation lead, hub contact, framework owner or early-market-engagement route to pressure-test a safe demonstrator before any purchase decision exists?
A small, governed test. Not a rollout.
A bounded demonstrator could test whether a 50-person / 12-week continuity process can operate safely around existing services, with low partner burden and a claims-safe learning pack.
Held back
Enough to know this needs a serious conversation. Not enough to hand over the system.
The full operating model, product mechanics, data boundaries, partner workflow, signal taxonomy and implementation sequence are held for qualified conversations and NDA review.
Request a 30-minute exploratory route conversation → Private route conversation. Not a sales funnel.Out the other side
The route out is not another disconnected service. It is continuity around the person.
Dean Butler — Founder, OTOS Continuity™